$1.2M Awarded for Big Cancer-Research Ideas at Ohio State Through Pelotonia Grant Program
Awarded for Big Cancer-Research Ideas at Ohio State Through Pelotonia Grant
COLUMBUS, Ohio – Projects
designed to understand the genomics of metastatic cancers; implement a
Low Dose of Targeted Drug Might Improve Cancer-Killing Virus Therapy
Viruses designed to kill cancer cells are being used in clinical trials to treat brain cancer and other malignancies.
This study suggests that combining a particular targeted agent with a cancer-kill
The Ohio State University and University of Michigan Partner with Industry to Bring Oral Cancer-Fighting Patch to Patients
Ohio-based Venture Therapeutics Named
COLUMBUS, Ohio - The Ohio
State University and the University of Michigan have signed an exclusive
worldwide agreement with Ohio-based
Study of ‘Super Responder’ Reveals New Oncogene for Lung Cancer
Ohio — Researchers have taken the next step in confirming the identity of
previously unknown gene mutation that drives lung cancer development. Scientists
at The Ohio State University
Genetic Basis of Lung Cancer Different for African Americans, Study Suggests
COLUMBUS, Ohio – New research suggests that African Americans and Caucasians differ significantly in the genes that drive the most common form of lung cancer.
Scientists at The Ohio State Uni
Phase 3 Study Strengthens Support of Ibrutinib as Second-line Therapy for CLL
Columbus, Ohio – In a head-to-head
comparison of two Food and Drug Administration-approved drugs for the treatment
of relapsed chronic lymphocytic leukemia (CLL), ibrutinib significantly
Mechanisms of Ibrutinib Resistance Identified in Chronic Leukemia
Ibrutinib is a new and highly effective drug for chronic lymphocytic leukemia (CLL), a cancer of the blood that affects 15,700 people annually and has no cure.
In some people, CLL becomes resista
Ohio State and Moffitt Form World’s Largest Cancer Research Collaboration for Big Data; More Than 100,000 Patients Already Participating
TAMPA, Fla., and COLUMBUS, Ohio (May 28, 2014) – Two of North America’s leading cancer centers, Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Can
Summer/Fall Race Series Supports Cancer Research at Ohio State
Events in Bexley, Canal Winchester, Dublin and Columbus
Raise $300K for Local Research Annually
COLUMBUS, Ohio – The 2014 James 5K
race series kicks off Saturday, June 7, 2014, in Bexl
A Form of Immune Therapy Might be Effective for Multiple Myeloma
Craig Hofmeister, MD, MPH
Multiple myeloma is a cancer of the blood that is still incurable, and new therapies are urgently needed.
This study describes a type of immune therapy that might effe
A Gene Within a Gene Contributes to the Aggressiveness of Acute Myeloid Leukemia
High expression of a gene called BAALC is known to be associated with poor survival of acute myeloid leukemia (AML) patients.
BAALC has a second smaller gene embedded within it that is also active in
Study Identifies a Likely Key Driver of Colorectal Cancer Development and Progression
New targets are needed for agents that will more effectively treat colorectal cancer (CRC).
This study identifies a molecule that is probably a key driver of colorectal cancer.
The findings strongly
Ohio State Hematologist Recognized Nationally With Top 10 Clinical Research Achievement Award
COLUMBUS, Ohio – John C. Byrd, MD, has again received national scientific recognition for his translational research investigating use of the drug, ibrutinib, in the treatment of chronic lymphocytic l
Well-Known Cancer Gene NRAS Produces Five Variants, Study Finds
NRAS is one of the most studied cancer-related genes.
This study found that the gene produces five variants, not just one form as thought.
The finding might help improve drugs for cancers that i
Ohio State Recognizes Cancer ‘Champions’ at April 9 Awards Luncheon
Honorees selected from Ohio, Wisconsin and California
COLUMBUS, Ohio – Four individuals, a grassroots fundraising organization and major corporation will be recognized as cancer “champions” W
Innovative ‘False Pedicle’ Surgery Allows for Advanced Spinal/Pelvic Reconstruction
Ohio State team pioneers surgical technique to stabilize the spine and pelvis in complex bone cancer removal
COLUMBUS, Ohio – A multidisciplinary team at The Ohio State University Comprehensive C
Inhibition of CDK4 Might Promote Lymphoma Development and Progression
Inhibitors of CDK4, a protein that helps regulate the cell cycle, have been shown to inhibit cancer in some tumor types.
This new study found that inhibiting this molecule can cause genetic instabilit
Ohio State Partners with MedVax Technologies, Inc. to Bring a Cancer Peptide Vaccine to Patients
COLUMBUS, Ohio, and MIAMI, Florida – The Ohio State University, through the Ohio State Innovation Foundation, has signed an exclusive world-wide licensing agreement with MedVax Technologies, Inc., for
Study Identifies Possible New Target for Future Brain Cancer Drugs
Glioblastoma multiforme (GBM) is a lethal brain cancer that has an average survival of 15 months, so there is a critical need for new treatments.
This study found that GBM tumors that have high lev
Study of ‘Super Responder’ Reveals Possible New Gene Target for Lung Cancer
COLUMBUS, Ohio — A potential new gene mutation that might drive lung cancer development and growth has been identified by researchers at The Ohio State University Comprehensive Cancer Center – Arthur